Form 4 for BIIB Biogen
Accepted 2022-12-12 00:00:00 ET · period of report 2022-12-08 · accession 0001127602-22-027340 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-12 | 2022-12-08 | BIIB | Kramer Robin | CAO | F - Tax | $289.10 | -156 | 2,212 | -7% | -$45.1K |
| D | 2022-12-12 | 2022-12-08 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | +350 | 2,368 | +17% | $0 |
| D | 2022-12-12 | 2022-12-08 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | -350 | 702 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-08 | F | D | 156 | $289.10 | 2,211.75 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-08 | M | A | 350 | $0.00 | 2,367.75 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2022-12-08 | M | D | 350 | $0.00 | 702 | D | $0.00 · — to 2024-12-08 | 350 Common Stock | (F1) The restricted stock units vest in three (3) equal annual installments commencing on the first anniversary of the grant date of 12/8/2021. |